Experiences with Tavanic

This page shows detailed information about a medicine such as statistics, patient reviews and related articles.

Active ingredient: levofloxacin hemihydrate
ATC Code: J01MA12

Level of
Satisfaction

Level of Satisfaction 25%

What patients say...

Effectiveness 62%
Quantity of side effects 87%
Severity of side effects 62%
Ease of use 75%

Our patients

Our patients, demographics

Read our patient's reviews about Tavanic

Filter reviews by...

hide filters...
translation feature available for reviews from other countries
Tavanic
13/08/2017 | | 67moderated by Susan
levofloxacin hemihydrate (500mg) for epididymitis

Pain and bacteria after one day of at least 5, so the course is doing its job, but still 5 days to go and muscle pain in my hip and Achilles tendon. I'll be glad once this is over.
> read full review...

Tavanic
06/06/2017 | | 69moderated by Henry
levofloxacin hemihydrate (500mg) for urinary tract infection (UTI)

painful joints, even after being off this medicine for a month it's still difficult for me to walk. Pain in my shoulders and back. Feel ill. Feel like I won't ever get better. Disgusting medicine. Was supposed to have helped with a recurring bladder infection but instead this drug has ruined me. Never again! Advised my pharmacist about this!
> read full review...

Most reviewed medicines


The content on this page is user-generated content, read and revised before approval to comply with our standards for a medicine review or reaction. We do not enforce any proven medical knowledge from our users to allow them to present their experiences. This way, the opinions and experiences described state only the views of the writers and not those of the owner of this website. Remember that these experiences differ from person to person and that you should always contact your doctor or pharmacist for advice on medication.

Copyright © 2008-2024 Insight Pharma Services BV.
All rights reserved.
Most icons from FontAwesome. Some icons made by Prosymbols from www.flaticon.com and licensed as CC 3.0 BY.